Bharat Petroleum Corporation

Similar documents
TVS Motors. Source: Company Data; PL Research

Reliance Industries. Impressive performance. Source: Company Data; PL Research

Indraprastha Gas. Growth traction continues. Source: Company Data; PL Research

Cummins India. Source: Company Data; PL Research

Maruti Suzuki. Source: Company Data; PL Research

Coal India. Source: Company Data; PL Research

Asian Paints. Source: Company Data; PL Research

Mahindra & Mahindra. Source: Company Data; PL Research

Bharat Forge. Exports remain subdued, outlook better. Source: Company Data; PL Research

Source: Company Data; PL Research

Siemens. Railways and T&D driving inflows. Source: Company Data; PL Research

Coal India. Source: Company Data; PL Research

JK Lakshmi Cement. Source: Company Data; PL Research

Crompton Greaves. Looking to exit overseas Power segment! Source: Company Data; PL Research

Maruti Suzuki. Source: Company Data; PL Research

Cummins India. Growth/margin bottoming. Source: Company Data; PL Research

SpiceJet. Healthy operating performance in Q2. Source: Company Data; PL Research

Asian Paints. Source: Company Data; PL Research

Mphasis. Increased confidence on margins. Source: Company Data; PL Research

Thermax. Source: Company Data; PL Research

Coal India. Source: Company Data; PL Research

Maruti Suzuki. In a league of its own ; Buy. Source: Company Data; PL Research

Britannia Industries

Eicher Motors. Continues to ride high! Accumulate. Source: Company Data; PL Research

Hindustan Zinc. Source: Company Data; PL Research

Coal India. Source: Company Data; PL Research

Allcargo Logistics. Source: Company Data; PL Research

Persistent Systems. Growth led by Enterprise Retain BUY. Source: Company Data; PL Research

Indraprastha Gas. Source: Company Data; PL Research

Bharat Electronics. Best defence play. Source: Company Data; PL Research

NIIT Technologies. Strong growth in core services. Source: Company Data; PL Research

Ultratech Cement. Source: Company Data; PL Research

Larsen & Toubro. Decent performance! Source: Company Data; PL Research

Hindalco Industries. Source: Company Data; PL Research

Tata Motors. Source: Company Data; PL Research

Ashok Leyland. Source: Company Data; PL Research

Cummins India. Focusing on growth in core segments. Source: Company Data; PL Research

Tech Mahindra. Source: Company Data; PL Research

Hindustan Zinc. Source: Company Data; PL Research

Jindal Steel & Power

Crompton Greaves Consumer Electricals

Sonata Software. Strong growth, reasonable valuations. Source: Company Data; PL Research

Mphasis. Source: Company Data; PL Research

Tata Motors. Source: Company Data; PL Research

Cadila Healthcare. Source: Company Data; PL Research

Crompton Greaves Consumer Electricals

Dr. Lal PathLabs. Source: Company Data; PL Research

Eicher Motors. Source: Company Data; PL Research

Navneet Education. ILL loss hurts consolidated earnings growth. Source: Company Data; PL Research

Jindal Steel & Power

Bharat Forge. Growth on all fronts; Accumulate. Source: Company Data; PL Research

Source: Company Data; PL Research

HDFC Standard Life Insurance

Indian Oil Corporation (IOCL IN)

Hindustan Unilever. In the Pink of Health ; Accumulate. Source: Company Data; PL Research

Glenmark Pharmaceuticals

Va Tech Wabag. On track for a strong H2FY16. Source: Company Data; PL Research

LIC Housing Finance. Source: Company Data; PL Research

Aurobindo Pharma. Source: Company Data; PL Research

Colgate Palmolive. Source: Company Data; PL Research

S Chand and Company. TP of Rs679 (implying PER of 20x FY19E earnings) Source: Company Data; PL Research

Larsen & Toubro. Source: Company Data; PL Research

Source: Company Data; PL Research

Aurobindo Pharma. Source: Company Data; PL Research

ICICI Prudential Life Insurance

Dabur India. Source: Company Data; PL Research

Britannia Industries

Tata Steel. Source: Company Data; PL Research

Punjab National Bank

Dr. Reddy's Laboratories

NIIT Technologies. Source: Company Data; PL Research

Tata Motors. Turnaround 2.0, Fit for future; BUY. Source: Company Data; PL Research

GMR Infrastructure. Airport revenues on a thaw, Power awaiting its turn. Q3FY13 Result Update

Hindustan Zinc. Strong show, H2 to be stronger than H1. Source: Company Data; PL Research

VRL Logistics. Steady show in tough environment. Source: Company Data; PL Research

Need to pull up the socks. Source: Company Data; PL Research

Dabur India. Steady recovery in place; Accumulate. Source: Company Data; PL Research

Gujarat State Fertilisers & Chemicals

LIC Housing Finance. Stable performance. Source: Company Data; PL Research

Capital First. Continuing to grow strong. Source: Company Data; PL Research

Punjab National Bank

Dabur India. Worst is over; Accumulate. Source: Company Data; PL Research

BHEL.BO BHEL IN. Structural story remains weak. Q1FY19 Result Update. Rating: REDUCE CMP: Rs72 TP: Rs73. July 25, 2018

Bayer Cropscience (BYRCS IN)

Crompton Greaves Consumer Electricals (CROMPTON IN) Rating: BUY CMP: Rs195 TP: Rs276

Cig volumes surprise. Source: Company Data; PL Research

Cadila Healthcare. Source: Company Data; PL Research

Dabur India. Share gains power growth, Accumulate. Source: Company Data; PL Research

SBI Life Insurance Company (SBILIFE IN ) Rating: BUY CMP: Rs673 TP: Rs840

FY20E FY21E FY20E FY21E

Glenmark Pharmaceuticals

Lupin Result beats expectations; Near term revenue drivers improves grows visibility

Coal India. Rs340, EV/EBITDA of 6.5x FY20E. Source: Company Data; PL Research

Cadila Healthcare. Source: Company Data; PL Research

Glenmark Pharmaceuticals

Dr. Reddy's Laboratories

Mindtree. Source: Company Data; PL Research.

NIIT Technologies. Source: Company Data; PL Research

Bharat Forge. Strong traction in exports. (our estimate Rs730m). Source: Company Data; PL Research

Aurobindo Pharma. Source: Company Data; PL Research

Transcription:

Higher inventory loss drag earnings August 14, 2017 Avishek Datta avishekdatta@plindia.com +91 22 66322254 Rating BUY Price Rs479 Target Price Rs553 Implied Upside 15.4% Sensex 31,449 Nifty 9,794 (Prices as on August 14, 2017) Trading data Market Cap. (Rs bn) 692.2 Shares o/s (m) 1,446.2 3M Avg. Daily value (Rs m) 1876.1 Major shareholders Promoters 55.79% Foreign 22.17% Domestic Inst. 7.05% Public & Other 14.99% Stock Performance (%) 1M 6M 12M Absolute 3.7 6.3 26.8 Relative 5.5 (4.6) 15.1 How we differ from Consensus EPS (Rs) PL Cons. % Diff. 2018 53.6 42.2 27.1 2019 63.0 47.3 33.2 Price Performance (RIC: BPCL.BO, BB: BPCL IN) (Rs) 600 500 400 300 200 100 0 Aug 16 Oct 16 Source: Bloomberg Dec 16 Feb 17 Apr 17 Jun 17 Aug 17 Strong operating performance hit by inventory loss: BPCL reported Q1FY18 results lower than estimates; EBITDA at Rs12.3bn (PLe: Rs21.1bn) and PAT at Rs7.4bn (PLe: Rs13.6bn). Operating profits were hit by higher than expected inventory loss of Rs13.6bn and other expenses of Rs33.3bn (+12%QoQ). We remain positive on OMCs as benign crude price outlook along with stable refining and marketing margins are likely to drive earnings. GRMs steady: BPCL s refining margins for Q1FY18 were at US$4.9/bbl (Q4FY17 at US$6.0/bbl) due to inventory loss of US$2.0/bbl. Refining margins came in lower to peers due to use of light crude at the Kochi refinery given ongoing stabilisation of expanded capacity. Refining throughput for Q1 was at 6.4MTPA (6.0MTPA in Q4) post maintenance shutdown at Mumbai refinery. Marketing volumes grows, but lower than industry: BPCL s Q1FY18 marketing profitability was hit by inventory loss of Rs7.3bn. For Q1, BPCL s diesel and petrol marketing volume growth was at 1.7% YoY and 9.7 YoY, respectively, lower than industry rate of 5.8% and 10.6%YoY, respectively, due to increased competition from private players. BPCL has more retail outlets on highways and is planning new strategy to limit market share loss. Gross marketing margins for diesel and petrol for Q1 were steady at Rs2.7/2.6/litre. Marketing earnings are expected to remain strong, going forward, due to healthy volume growth and stable margins. Maintain estimates, reiterate BUY : We maintain our estimates for FY18/19E. Reiterate BUY with a PT of Rs553 (unchanged) based on 12x FY19E. We also add the investments at 25% discount to market and add the value of E&P. Key financials (Y/e March) 2016 2017 2018E 2019E Revenues (Rs m) 1,878,146 2,012,507 2,163,529 2,527,487 Growth (%) (22.6) 7.2 7.5 16.8 EBITDA (Rs m) 129,371 135,125 121,415 139,812 PAT (Rs m) 80,889 95,070 77,575 91,152 EPS (Rs) 55.9 65.7 53.6 63.0 Growth (%) 68.3 17.5 (18.4) 17.5 Net DPS (Rs) 15.5 19.5 18.0 21.0 Profitability & Valuation 2016 2017 2018E 2019E EBITDA margin (%) 6.9 6.7 5.6 5.5 RoE (%) 32.0 30.8 21.5 22.1 RoCE (%) 16.2 14.6 11.5 11.3 EV / sales (x) 0.4 0.4 0.4 0.4 EV / EBITDA (x) 6.5 6.2 7.2 6.6 PE (x) 8.6 7.3 8.9 7.6 P / BV (x) 2.5 2.1 1.8 1.6 Net dividend yield (%) 3.2 4.1 3.8 4.4 Source: Company Data; PL Research Q1FY18 Result Update Prabhudas Lilladher Pvt. Ltd. and/or its associates (the 'Firm') does and/or seeks to do business with companies covered in its research reports. As a result investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of the report. Investors should consider this report as only a single factor in making their investment decision. Please refer to important disclosures and disclaimers at the end of the report

Conference call takeaway Kochi project update: Management mentioned that the Kochi refinery expansion is on track and full benefits will be reflected from Q4FY18 when the secondary units operate at ~90%. When fully commissioned, management expects incremental benefit of US$2/bbl on full capacity and opex increase of US$0.5/bbl. Private completion impacting fuel demand growth: Management clarified that BPCL has lost market share to PSU peers. BPCL management remains confident of defending market share and is planning new marketing strategies to counter competitive threats. Capex guidance: BPCL expects capex of Rs78/85bn for FY18/19E. Subsidiaries record healthy GRM: For Q1, Bina refinery had profits of Rs1.46bn and GRMs were at US$8.9/bbl. The Numaligarh refinery had PAT of Rs3.7bn for Q1 and excluding excise duty benefits had GRMs of US$7.5/bbl. GST impact: BPCL expects GST impact of Rs10bn and is actively discussing with the state governments to include petroleum products in the GST regime. August 14, 2017 2

Exhibit 1: Q1FY18 Result Overview (Rs m) Y/e March Q1FY18 Q1FY17 YoY gr. (%) Q4FY17 QoQ gr. (%) Net sales 667,664 570,158 17.1 660,232 1.1 Inc/dec in stock 24,689 (24,097) NA (17,674) NA Raw material cons 171,590 147,458 16.4 182,067 (5.8) Staff cost 8,087 6,493 24.5 14,368 (43.7) Purchases 321,363 270,767 18.7 340,372 (5.6) Duties, taxes, etc 96,406 100,771 (4.3) 89,867 7.3 Other expenditure 33,278 29,574 12.5 29,109 14.3 Exp (655,413) (530,966) NA (638,110) NA Operating profit 12,250 39,192 (68.7) 22,123 (44.6) Interest (1,789) (1,111) NA (1,475) NA Depreciation (5,892) (4,315) NA (5,238) NA Other income 6,566 3,649 79.9 6,624 (0.9) Profit before tax 11,136 37,415 (70.2) 22,033 (49.5) Current tax (3,690) (11,210) NA (3,616) NA Profit after tax 7,446 26,205 (71.6) 18,417 (59.6) Source: Company Data, PL Research Exhibit 2: BPCL refining margin and volume details Q3FY16 Q4FY16 Q1FY16 Q2FY17 Q3FY17 Q4FY17 Q1FY18 Refining volume (MT) 5.9 6.2 6.2 6.4 6.8 6.0 6.4 GRM ($/bbl) 7.7 6.3 6.1 3.1 5.9 6.0 4.9 Marketing volume (MTPA) 9.3 9.8 9.7 8.9 9.8 9.2 10.0 Source: Company Data, PL Research August 14, 2017 3

Income Statement (Rs m) Net Revenue 1,878,146 2,012,507 2,163,529 2,527,487 Raw Material Expenses 902,403 1,021,312 882,766 1,037,749 Gross Profit 975,743 991,195 1,280,763 1,489,738 Employee Cost Other Expenses 846,372 856,070 1,159,348 1,349,926 EBITDA 129,371 135,125 121,415 139,812 Depr. & Amortization 20,719 21,076 29,357 30,235 Net Interest (9,154) (13,514) (17,275) (18,444) Other Income 15,958 20,478 28,898 32,153 Profit before Tax 117,806 127,562 109,333 128,021 Total Tax 40,427 41,926 31,348 36,520 Profit after Tax 77,379 85,636 77,985 91,500 Ex Od items / Min. Int. (3,510) (9,434) 410 348 Adj. PAT 80,889 95,070 77,575 91,152 Avg. Shares O/S (m) 1,446.2 1,446.2 1,446.2 1,446.2 EPS (Rs.) 55.9 65.7 53.6 63.0 Cash Flow Abstract (Rs m) C/F from Operations 100,762 149,601 202,751 217,703 C/F from Investing (118,422) (120,295) (197,883) (222,889) C/F from Financing 29,488 20,270 58,080 30,431 Inc. / Dec. in Cash 11,828 49,576 62,947 25,246 Opening Cash 34,463 46,290 95,866 158,813 Closing Cash 46,290 95,866 158,813 184,058 FCFF 32,848 (151,196) (95) (73,944) FCFE 88,940 (114,600) 99,774 4,480 Key Financial Metrics Growth Revenue (%) (22.6) 7.2 7.5 16.8 EBITDA (%) 32.3 4.4 (10.1) 15.2 PAT (%) 68.3 17.5 (18.4) 17.5 EPS (%) 68.3 17.5 (18.4) 17.5 Profitability EBITDA Margin (%) 6.9 6.7 5.6 5.5 PAT Margin (%) 4.3 4.7 3.6 3.6 RoCE (%) 16.2 14.6 11.5 11.3 RoE (%) 32.0 30.8 21.5 22.1 Balance Sheet Net Debt : Equity 0.5 0.4 0.5 0.5 Net Wrkng Cap. (days) (54) (62) (96) (96) Valuation PER (x) 8.6 7.3 8.9 7.6 P / B (x) 2.5 2.1 1.8 1.6 EV / EBITDA (x) 6.5 6.2 7.2 6.6 EV / Sales (x) 0.4 0.4 0.4 0.4 Earnings Quality Eff. Tax Rate 34.3 32.9 28.7 28.5 Other Inc / PBT 13.5 16.1 26.4 25.1 Eff. Depr. Rate (%) 3.4 2.4 2.8 2.3 FCFE / PAT 110.0 (120.5) 128.6 4.9 Source: Company Data, PL Research. Balance Sheet Abstract (Rs m) Shareholder's Funds 280,336 336,432 384,591 441,548 Total Debt 266,268 302,864 402,733 481,157 Other Liabilities 35,496 69,296 94,392 131,485 Total Liabilities 582,100 708,592 881,716 1,054,189 Net Fixed Assets 546,426 659,624 827,966 1,020,477 Goodwill Investments Net Current Assets 35,674 48,968 53,751 33,712 Cash & Equivalents 123,653 159,249 222,381 247,769 Other Current Assets 262,335 257,953 236,522 253,576 Current Liabilities 350,313 368,235 405,153 467,633 Other Assets Total Assets 582,101 708,592 881,716 1,054,189 Quarterly Financials (Rs m) Y/e March Q2FY17 Q3FY17 Q4FY17 Q1FY18E Net Revenue 549,132 640,957 660,232 667,664 EBITDA 13,814 33,165 22,123 12,250 % of revenue 2.5 5.2 3.4 1.8 Depr. & Amortization 4,524 4,836 5,238 5,892 Net Interest (9,199) (4,162) (5,149) (4,777) Other Income 10,223 5,511 6,624 6,566 Profit before Tax 18,489 32,491 22,033 11,136 Total Tax 5,437 9,771 3,616 3,690 Profit after Tax 13,052 22,719 18,417 7,446 Adj. PAT 13,052 22,719 18,417 7,446 Key Operating Metrics Crude /bbl 47.6 49.0 55.0 60.0 US$/Rs 65.4 67.1 66.0 67.0 GRM (US$/bbl) 6.6 5.3 6.0 6.5 Refining volume (MTPA) 24.1 25.4 29.4 31.4 Net subsidy burden (Rs m) Source: Company Data, PL Research. August 14, 2017 4

Prabhudas Lilladher Pvt. Ltd. 3rd Floor, Sadhana House, 570, P. B. Marg, Worli, Mumbai 400 018, India Tel: (91 22) 6632 2222 Fax: (91 22) 6632 2209 Rating Distribution of Research Coverage PL s Recommendation Nomenclature % of Total Coverage 50% 40% 30% 20% 10% 0% 45.2% 37.9% 16.9% 0.0% BUY Accumulate Reduce Sell BUY : Over 15% Outperformance to Sensex over 12 months Accumulate : Outperformance to Sensex over 12 months Reduce : Underperformance to Sensex over 12 months Sell : Over 15% underperformance to Sensex over 12 months Trading Buy : Over 10% absolute upside in 1 month Trading Sell : Over 10% absolute decline in 1 month Not Rated (NR) : No specific call on the stock Under Review (UR) : Rating likely to change shortly DISCLAIMER/DISCLOSURES ANALYST CERTIFICATION We/I, Mr. Avishek Datta (MBA), Research Analysts, authors and the names subscribed to this report, hereby certify that all of the views expressed in this research report accurately reflect our views about the subject issuer(s) or securities. We also certify that no part of our compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report. Terms & conditions and other disclosures: Prabhudas Lilladher Pvt. Ltd, Mumbai, India (hereinafter referred to as PL ) is engaged in the business of Stock Broking, Portfolio Manager, Depository Participant and distribution for third party financial products. PL is a subsidiary of Prabhudas Lilladher Advisory Services Pvt Ltd. which has its various subsidiaries engaged in business of commodity broking, investment banking, financial services (margin funding) and distribution of third party financial/other products, details in respect of which are available at www.plindia.com This document has been prepared by the Research Division of PL and is meant for use by the recipient only as information and is not for circulation. This document is not to be reported or copied or made available to others without prior permission of PL. It should not be considered or taken as an offer to sell or a solicitation to buy or sell any security. The information contained in this report has been obtained from sources that are considered to be reliable. However, PL has not independently verified the accuracy or completeness of the same. Neither PL nor any of its affiliates, its directors or its employees accepts any responsibility of whatsoever nature for the information, statements and opinion given, made available or expressed herein or for any omission therein. Recipients of this report should be aware that past performance is not necessarily a guide to future performance and value of investments can go down as well. The suitability or otherwise of any investments will depend upon the recipient's particular circumstances and, in case of doubt, advice should be sought from an independent expert/advisor. Either PL or its affiliates or its directors or its employees or its representatives or its clients or their relatives may have position(s), make market, act as principal or engage in transactions of securities of companies referred to in this report and they may have used the research material prior to publication. PL may from time to time solicit or perform investment banking or other services for any company mentioned in this document. PL is in the process of applying for certificate of registration as Research Analyst under Securities and Exchange Board of India (Research Analysts) Regulations, 2014 PL submits that no material disciplinary action has been taken on us by any Regulatory Authority impacting Equity Research Analysis activities. PL or its research analysts or its associates or his relatives do not have any financial interest in the subject company. PL or its research analysts or its associates or his relatives do not have actual/beneficial ownership of one per cent or more securities of the subject company at the end of the month immediately preceding the date of publication of the research report. PL or its research analysts or its associates or his relatives do not have any material conflict of interest at the time of publication of the research report. PL or its associates might have received compensation from the subject company in the past twelve months. PL or its associates might have managed or co managed public offering of securities for the subject company in the past twelve months or mandated by the subject company for any other assignment in the past twelve months. PL or its associates might have received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months. PL or its associates might have received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months PL or its associates might have received any compensation or other benefits from the subject company or third party in connection with the research report. PL encourages independence in research report preparation and strives to minimize conflict in preparation of research report. PL or its analysts did not receive any compensation or other benefits from the subject Company or third party in connection with the preparation of the research report. PL or its Research Analysts do not have any material conflict of interest at the time of publication of this report. It is confirmed that Mr. Avishek Datta (MBA), Research Analysts of this report have not received any compensation from the companies mentioned in the report in the preceding twelve months Compensation of our Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions. The Research analysts for this report certifies that all of the views expressed in this report accurately reflect his or her personal views about the subject company or companies and its or their securities, and no part of his or her compensation was, is or will be, directly or indirectly related to specific recommendations or views expressed in this report. The research analysts for this report has not served as an officer, director or employee of the subject company PL or its research analysts have not engaged in market making activity for the subject company Our sales people, traders, and other professionals or affiliates may provide oral or written market commentary or trading strategies to our clients that reflect opinions that are contrary to the opinions expressed herein, and our proprietary trading and investing businesses may make investment decisions that are inconsistent with the recommendations expressed herein. In reviewing these materials, you should be aware that any or all o the foregoing, among other things, may give rise to real or potential conflicts of interest. PL and its associates, their directors and employees may (a) from time to time, have a long or short position in, and buy or sell the securities of the subject company or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the subject company or act as an advisor or lender/borrower to the subject company or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions. DISCLAIMER/DISCLOSURES (FOR US CLIENTS) ANALYST CERTIFICATION The research analysts, with respect to each issuer and its securities covered by them in this research report, certify that: All of the views expressed in this research report accurately reflect his or her or their personal views about all of the issuers and their securities; and No part of his or her or their compensation was, is or will be directly related to the specific recommendation or views expressed in this research report Terms & conditions and other disclosures: This research report is a product of Prabhudas Lilladher Pvt. Ltd., which is the employer of the research analyst(s) who has prepared the research report. The research analyst(s) preparing the research report is/are resident outside the United States (U.S.) and are not associated persons of any U.S. regulated broker dealer and therefore the analyst(s) is/are not subject to supervision by a U.S. broker dealer, and is/are not required to satisfy the regulatory licensing requirements of FINRA or required to otherwise comply with U.S. rules or regulations regarding, among other things, communications with a subject company, public appearances and trading securities held by a research analyst account. This report is intended for distribution by Prabhudas Lilladher Pvt. Ltd. only to "Major Institutional Investors" as defined by Rule 15a 6(b)(4) of the U.S. Securities and Exchange Act, 1934 (the Exchange Act) and interpretations thereof by U.S. Securities and Exchange Commission (SEC) in reliance on Rule 15a 6(a)(2). If the recipient of this report is not a Major Institutional Investor as specified above, then it should not act upon this report and return the same to the sender. Further, this report may not be copied, duplicated and/or transmitted onward to any U.S. person, which is not the Major Institutional Investor. In reliance on the exemption from registration provided by Rule 15a 6 of the Exchange Act and interpretations thereof by the SEC in order to conduct certain business with Major Institutional Investors, Prabhudas Lilladher Pvt. Ltd. has entered into an agreement with a U.S. registered broker dealer, Marco Polo Securities Inc. ("Marco Polo"). Transactions in securities discussed in this research report should be effected through Marco Polo or another U.S. registered broker dealer. August 14, 2017 5